Trevogrumab is a monoclonal antibody research compound that selectively targets growth differentiation factor 8 (GDF-8, myostatin). It is used in laboratory and experimental studies focused on muscle biology, myostatin signaling pathways, and mechanisms regulating muscle growth and maintenance.
Related products
Sale!
Sale!
